# Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy

> **NCT04174456** · NA · UNKNOWN · sponsor: **Dong-A University** · enrollment: 40 (estimated)

## Conditions studied

- Dilated Cardiomyopathy

## Interventions

- **DIAGNOSTIC_TEST:** FDG PET

## Key facts

- **NCT ID:** NCT04174456
- **Lead sponsor:** Dong-A University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2021-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04174456

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04174456, "Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04174456. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*